Liver SteatosesNCT03542578
Diagnosis of Fatty Liver With Outpatient Ultrasound
An observational study of Liver Steatoses, run by Medical College of Wisconsin at 1 site in United States.
Trial summary
This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Liver Steatoses
- What is being tested?
- outpatient evaluation of fatty liver
- Type of treatment
- Medical device
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Sep 2018to 9 Jul 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: All patients presenting outpatient clinic will be evaluated
Who may be able to join
- all patients presenting to dedicated clinic
Who cannot join
- presence of ascites, inability to give consent to have study
Trial locations and contacts
1 site in 1 country.
About this study
This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver.
Read the detailed description
All patients presenting to dedicated hepatology clinic with concern for fatty liver will be evaluated by ultrasound. This will be compared with standard imaging performed for this condition. The data will be compared for effectiveness of outpatient evaluation with dedicated imaging currently practiced
- Conditions
- Liver Steatoses
- Being tested
- outpatient evaluation of fatty liver
- Medical subject headings
- Fatty Liver
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
outpatient evaluation of fatty liverDevice
outcome of ultrasound evaluation of liver in clinical outpatient settings
What is being measured
The primary outcome is the main question the study is designed to answer.
Outpatient ultrasound in diagnosis of fatty liver diagnosis
Effectiveness of outpatient evaluation by outpatient bedside ultrasound device in diagnosis of fatty liver compared to standard radiological evaluation. Comparing presence and severity of steatosis reported by standard radiological imaging with bed side imaging tool.
Measured: Bedside evaluation performed after consent and compared with radiological imaging perfomed within 3 months of this bedside evaluation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 May 2018
- Study start12 Sep 2018
- Primary completion9 Jul 2026
- Study completion9 Jul 2026
Why it stopped: Changes in the study staff's role and clinic commitments
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Liver SteatosesStudies of the same condition, open and under way.
- More trials run by Medical College of WisconsinThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medical College of Wisconsin
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Achuthan Sourianarayanane, Medical College of Wisconsin
- Investigators
- Achuthan Sourianarayanane, MD, Principal investigator, Medical College of Wisconsin
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03542578
- Sponsor's protocol ID
- PRO00029401
- Status last verified
- Jul 2026
- First submitted
- 24 Apr 2018
- Last updated
- 13 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Diagnosis of Fatty Liver With Outpatient Ultrasound
- ClinicalTrials.gov ID
- NCT03542578
- Acronym / sponsor ID
- PRO00029401
- Conditions
- Liver Steatoses
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Changes in the study staff's role and clinic commitments
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Medical College of WisconsinUniversity, hospital or other
- Study start
- 12 Sep 2018 (actual)
- Primary completion
- 9 Jul 2026 (actual)
- Study completion
- 9 Jul 2026 (actual)
- First posted
- 31 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver.
Detailed description
All patients presenting to dedicated hepatology clinic with concern for fatty liver will be evaluated by ultrasound. This will be compared with standard imaging performed for this condition. The data will be compared for effectiveness of outpatient evaluation with dedicated imaging currently practiced
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- All patients presenting outpatient clinic will be evaluated
Key inclusion criteria (1 listed)
- all patients presenting to dedicated clinic
Key exclusion criteria (1 listed)
- presence of ascites, inability to give consent to have study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| outpatient evaluation of fatty liveroutcome of ultrasound evaluation of liver in clinical outpatient settings | Device | – |
Primary outcome
Outpatient ultrasound in diagnosis of fatty liver diagnosis
Time frame: Bedside evaluation performed after consent and compared with radiological imaging perfomed within 3 months of this bedside evaluation
Effectiveness of outpatient evaluation by outpatient bedside ultrasound device in diagnosis of fatty liver compared to standard radiological evaluation. Comparing presence and severity of steatosis reported by standard radiological imaging with bed side imaging tool.
Results and safety
The study was stopped early (reason given: Changes in the study staff's role and clinic commitments). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Liver Steatoses
Not yet recruiting
Efficacy of Carnitine Complex in Improving Hepatic Steatosis in Potential Liver Donors
Hepatic Steatosis, Fatty Liver
RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
RecruitingPhase 1
A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH
Metabolic Dysfunction-Associated Steatohepatitis
Recruiting
Dietary Intervention Study on Liver Health in Young Adults
Liver Health
Recruiting
NAFLD Clinical Care Pathway
NAFLD, MASLD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Achuthan Sourianarayanane, MD principal investigator
Medical College of Wisconsin
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Liver Steatoses, run by Medical College of Wisconsin at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Changes in the study staff's role and clinic commitments). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Outpatient ultrasound in diagnosis of fatty liver diagnosis (time frame: Bedside evaluation performed after consent and compared with radiological imaging perfomed within 3 months of this bedside evaluation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.